Study | ➀ | ➁ | ➂ | ➃ | ➄ | ➅ | ➆ | ➇ | ➈ | ➉ | Quality score |
---|
Wang YC et al. 2014 | √ | √ | √ | | √ | | √ | √ | | √ | 7 |
Bombi Lee et al. 2013 | √ | √ | √ | √ | √ | | √ | √ | | √ | 8 |
Song XY et al. 2013 | √ | √ | √ | | | | √ | √ | | √ | 6 |
Quan QK et al. 2013 | √ | √ | | | | | √ | √ | √ | √ | 6 |
Zhao HH et al. 2012 | √ | √ | | | | | √ | √ | √ | √ | 6 |
Wang YL et al. 2010 | √ | √ | | | √ | | | ? | | √ | 4 |
Zhang X et al. 2012 | √ | √ | √ | | √ | | √ | √ | √ | √ | 8 |
Chu SH et al. 2014 | √ | | √ | | | | √ | ? | | √ | 4 |
Zhou LP et al. 2011 | √ | √ | | | | | | √ | | √ | 4 |
Wang XY et al. 2001 | √ | √ | √ | | | | √ | √ | | √ | 6 |
Wu W et al. 2011 | √ | √ | | | | | | √ | | √ | 4 |
Zang Y et al. 2010 | √ | √ | √ | | | | | √ | | √ | 5 |
- (1) peer reviewed publication; (2) presence of randomization of subjects into treatment groups; (3) assessment of dose–response relationship; (4) blinded assessment of behavioural outcome; (5) monitoring of physiological parameters such as body temperature; (6) calculation of necessary sample size to achieve sufficient power; (7) statement of compliance with animal welfare regulations; (8) avoidance of anaesthetic agents with marked intrinsic neuroprotective properties (e.g., ketamine); (9) statement of potential conflict of interests; (10) use of a suitable animal model